The DOI matches its Crossref record; 195 of the 195 references it cites were found in a registry or an index.
Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective
Open accessAbstract
Graphical abstract
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Yan, X., Qian, H., Mu, Y., Timani, K. A., Ye, L., Zhu, Y., & Wu, J. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.02.003 · Cited by 134
RetractedHeart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036 · cited 1×
“2 billion which reconfirms the severity of the disease and the economic burden on society [150].”
Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231232a0 · Cited by 8,605
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
Chen, X., Xiu, M., Xing, J., Yu, S., Min, D., & Guo, F. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479439 · Cited by 5,742
Bombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B., Day, R., Ferraz, M. B., Hawkey, C. J., Hochberg, M. C., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432103 · Cited by 4,027
Vane, J. R., Bakhle, Y. S., & Botting, R. M. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.97 · Cited by 2,734
Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., & Simmons, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162468699 · Cited by 1,989
Xie, W. L., Chipman, J. G., Robertson, D. L., Erikson, R. L., & Simmons, D. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.7.2692 · Cited by 1,707
Lee, W. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021844 · Cited by 1,594
Warner, T. D., Giuliano, F., Vojnovic, I., Bukasa, A., Mitchell, J. A., & Vane, J. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7563 · Cited by 1,519
Thun, M. J., Henley, S. J., & Patrono, C. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.4.252 · Cited by 1,433
Grosser, T. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27291 · Cited by 1,027
Prostanoid Receptors: Subtypes and Signaling
Breyer, R. M., Bagdassarian, C. K., Myers, S. A., & Breyer, M. D. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.661 · Cited by 1,011
A Comprehensive Review of Non-Steroidal Anti-Inflammatory Drug Use in The Elderly
Wongrakpanich, S., Wongrakpanich, A., Melhado, K., & Rangaswami, J. (2018) · Aging and disease · doi:10.14336/ad.2017.0306 · Cited by 917
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis
Nissen, S. E., Yeomans, N. D., Solomon, D. H., Lüscher, T. F., Libby, P., Husni, M. E., Graham, D. Y., Borer, J. S., Wisniewski, L. M., Wolski, K. E., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1611593 · Cited by 856
Rao, P., & Knaus, E. E. (2008) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3t886 · Cited by 773
Oxidant Mechanisms in Renal Injury and Disease
Ratliff, B. B., Abdulmahdi, W., Pawar, R., & Wolin, M. S. (2016) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6665 · Cited by 694
Cyclooxygenases: structural and functional insights
Rouzer, C. A., & Marnett, L. J. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800042-jlr200 · Cited by 688
Selective COX-2 Inhibitors: A Review of Their Structure-Activity Relationships.
Zarghi, A., & Arfaei, S. (2011) · PubMed Central · Cited by 680
Use of NSAIDs in treating patients with arthritis
Crofford, L. J. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4174 · Cited by 650
An Evidence-Based Update on Nonsteroidal Anti-Inflammatory Drugs
Ong, C. K. S., Lirk, P., Tan, C. H., & Seymour, R. A. (2007) · Clinical Medicine & Research · doi:10.3121/cmr.2007.698 · Cited by 587
Nonsteroidal anti-inflammatory drugs for dysmenorrhoea
Marjoribanks, J., Ayeleke, R. O., Farquhar, C., & Proctor, M. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001751.pub3 · Cited by 562
Visible small-intestinal mucosal injury in chronic NSAID users
Graham, D. Y., Opekun, A. R., Willingham, F. F., & Qureshi, W. A. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00603-2 · Cited by 551
Structural and Functional Basis of Cyclooxygenase Inhibition
Blobaum, A. L., & Marnett, L. J. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0613166 · Cited by 550
Prostanoids in health and disease
Smyth, E. M., Grosser, T., Wang, M., Yu, Y., & FitzGerald, G. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800094-jlr200 · Cited by 543
Mechanisms of Damage to the Gastrointestinal Tract From Nonsteroidal Anti-Inflammatory Drugs
Bjarnason, I., Scarpignato, C., Holmgren, E., Olszewski, M., Rainsford, K. D., & Lanas, A. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.10.049 · Cited by 530
Rapa, S. F., Di Iorio, B. R., Campiglia, P., Heidland, A., & Marzocco, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010263 · Cited by 519
A Quantitative Analysis of NSAID-Induced Small Bowel Pathology by Capsule Enteroscopy
Maiden, L., Thjodleifsson, B., Theodors, A., Gonzalez, J., & Bjarnason, I. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.020 · Cited by 499
Daniels, M. J. D., Rivers-Auty, J., Schilling, T., Spencer, N. G., Watremez, W., Fasolino, V., Booth, S. J., White, C. S., Baldwin, A. G., Freeman, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms12504 · Cited by 442
Gierse, J. K., McDonald, J. J., Hauser, S. D., Rangwala, S. H., Koboldt, C. M., & Seibert, K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.26.15810 · Cited by 410
Conaghan, P. G. (2012) · Rheumatology International · doi:10.1007/s00296-011-2263-6 · Cited by 407
Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage
Sostres, C., Gargallo, C. J., & Lanas, A. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4175 · Cited by 406
Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity
Boelsterli, U. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(03)00368-5 · Cited by 403
A Randomized, Double-Blind, Study of Rofecoxib in Patients with Mild Cognitive Impairment
on behalf of the Rofecoxib Protocol 078 study group, Thal, L. J., Ferris, S. H., Kirby, L., Block, G. A., Lines, C. R., Yuen, E., Assaid, C., Nessly, M. L., Norman, B. A., et al. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300690 · Cited by 402
Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent.
Rao, C. V., Rivenson, A., Simi, B., Zang, E. A., Kelloff, G. V., Steele, V. E., & Reddy, B. S. (1995) · PubMed · Cited by 402
Lapi, F., Azoulay, L., Yin, H., Nessim, S. J., & Suissa, S. (2013) · BMJ · doi:10.1136/bmj.e8525 · Cited by 393
(2014) · PubMed · Cited by 390
Cyclooxygenase-1 and -2–Dependent Prostacyclin Formation in Patients With Atherosclerosis
Belton, O., Byrne, D., Kearney, D., Leahy, A., & Fitzgerald, D. J. (2000) · Circulation · doi:10.1161/01.cir.102.8.840 · Cited by 377
Daly, A. K., Aithal, G. P., Leathart, J. B. S., Swainsbury, R. A., Dang, T. S., & Day, C. P. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.11.023 · Cited by 348
Anti-Inflammatory Agents for Cancer Therapy
Rayburn, E. (2009) · Molecular and Cellular Pharmacology · doi:10.4255/mcpharmacol.09.05 · Cited by 341
Identification of a phorbol ester-repressible v-src-inducible gene.
Simmons, D. L., Levy, D. B., Yannoni, Y., & Erikson, R. L. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.4.1178 · Cited by 316
The first 3500 years of aspirin history from its roots – A concise summary
Montinari, M. R., Minelli, S., & De Caterina, R. (2019) · Vascular Pharmacology · doi:10.1016/j.vph.2018.10.008 · Cited by 315
Somasundaram, S., Rafi, S., Hayllar, J., Sigthorsson, G., Jacob, M., Price, A. B., Macpherson, A., Mahmod, T., Scott, D., Wrigglesworth, J. M., et al. (1997) · Gut · doi:10.1136/gut.41.3.344 · Cited by 314
LEES, P., LANDONI, M. F., Giraudel, J., & TOUTAIN, P. L. (2004) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/j.1365-2885.2004.00617.x · Cited by 310
Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs
Lucas, G. N. C., Leitão, A. C. C., Alencar, R. L., Xavier, R. M. F., Daher, E. D. F., & Silva Junior, G. B. D. (2019) · Brazilian Journal of Nephrology · doi:10.1590/2175-8239-jbn-2018-0107 · Cited by 307
García Rodríguez, L. A., Tacconelli, S., & Patrignani, P. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.041 · Cited by 305
Cyclooxygenase-3 (COX-3): Filling in the gaps toward a COX continuum?
Warner, T. D., & Mitchell, J. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222543099 · Cited by 302
Renal Toxicity of the Nonsteroidal Anti-Inflammatory Drugs
Murray, M. D., & Brater, D. C. (1993) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.33.040193.002251 · Cited by 294
Biswas, K., Bandyopadhyay, U., Chattopadhyay, I., Varadaraj, A., Ali, E., & Banerjee, R. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210328200 · Cited by 291
Self-citationArfè, A., Scotti, L., Varas-Lorenzo, C., Nicotra, F., Zambon, A., Kollhorst, B., Schink, T., Garbe, E., Herings, R., Straatman, H., et al. (2016) · BMJ · doi:10.1136/bmj.i4857 · Cited by 290
Russell, B., Moss, C., Rigg, A., & Van Hemelrijck, M. (2020) · ecancermedicalscience · doi:10.3332/ecancer.2020.1023 · Cited by 286
Matsui, H., Shimokawa, O., Kaneko, T., Nagano, Y., Rai, K., & Hyodo, I. (2011) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.10-79 · Cited by 268
Aspirin-Exacerbated Respiratory Disease
White, A. A., & Stevenson, D. D. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1712125 · Cited by 258
Tsutsumi, S., Gotoh, T., Tomisato, W., Mima, S., Hoshino, T., Hwang, H.-J., Takenaka, H., Tsuchiya, T., Mori, M., & Mizushima, T. (2004) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401436 · Cited by 254
Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage?
Bessone, F. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i45.5651 · Cited by 248
Cooper, C., Chapurlat, R., Al-Daghri, N., Herrero-Beaumont, G., Bruyère, O., Rannou, F., Roth, R., Uebelhart, D., & Reginster, J.-Y. (2019) · Drugs & Aging · doi:10.1007/s40266-019-00660-1 · Cited by 248
Claria, J. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033454054 · Cited by 238
Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition
Jedlitschky, G., Hoffmann, U., & Kroemer, H. K. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.3.351 · Cited by 238
Diclofenac Toxicity to Hepatocytes: A Role for Drug Metabolism in Cell Toxicity
Bort, R., Ponsoda, X., Jover, R., Gómez-Lechón, M. J., & Castell, J. V. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37925-x · Cited by 236
Vascular COX-2 Modulates Blood Pressure and Thrombosis in Mice
Yu, Y., Ricciotti, E., Scalia, R., Tang, S. Y., Grant, G., Yu, Z., Landesberg, G., Crichton, I., Wu, W., Puré, E., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003787 · Cited by 236
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Barnham, M., & Anderson, A. W. (1997) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4899-1825-3_35 · Cited by 233
(2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.2.161 · Cited by 233
Emotion Recollected in Tranquility: Lessons Learned from the COX-2 Saga
Grosser, T., Yu, Y., & FitzGerald, G. A. (2010) · Annual Review of Medicine · doi:10.1146/annurev-med-011209-153129 · Cited by 232
Cardiovascular Risk of Nonsteroidal Anti-Inflammatory Drugs: An Under-Recognized Public Health Issue
Varga, Z., Sabzwari, S. R. A., & Vargova, V. (2017) · Cureus · doi:10.7759/cureus.1144 · Cited by 231
Dreischulte, T., Morales, D. R., Bell, S., & Guthrie, B. (2015) · Kidney International · doi:10.1038/ki.2015.101 · Cited by 217
Eicosanoids, prostacyclin and cyclooxygenase in the cardiovascular system
Mitchell, J. A., & Kirkby, N. S. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14167 · Cited by 216
The discovery of aspirin's antithrombotic effects.
Miner, J. J., & Hoffhines, A. J. (2007) · PubMed · Cited by 212
Role of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Cancer Prevention and Cancer Promotion
Wong, R. S. Y. (2019) · Advances in Pharmacological Sciences · doi:10.1155/2019/3418975 · Cited by 211
Indomethacin Has a Potent Antiviral Activity against Sars Coronavirus
Amici, C., Caro, A. D., Ciucci, A., Chiappa, L., Castilletti, C., Martella, V., Decaro, N., Buonavoglia, C., Capobianchi, M. R., & Santoro, M. G. (2006) · Antiviral Therapy · doi:10.1177/135965350601100803 · Cited by 203
NSAIDs and Cardiovascular Diseases: Role of Reactive Oxygen Species
Ghosh, R., Alajbegovic, A., & Gomes, A. V. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/536962 · Cited by 195
Role of mitochondrial permeability transition in diclofenac-induced hepatocyte injury in rats
Masubuchi, Y., Nakayama, S., & Horie, T. (2002) · Hepatology · doi:10.1053/jhep.2002.31871 · Cited by 184
PharmGKB summary: ibuprofen pathways
Mazaleuskaya, L. L., Theken, K. N., Gong, L., Thorn, C. F., FitzGerald, G. A., Altman, R. B., & Klein, T. E. (2015) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000113 · Cited by 182
Hepatocellular damage from non-steroidal anti-inflammatory drugs
O'connor, N., Dargan, P. I., & Jones, A. L. (2003) · QJM: An International Journal of Medicine · doi:10.1093/qjmed/hcg138 · Cited by 180
Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort
Breitner, J. C. S., Haneuse, S. J. P. A., Walker, R., Dublin, S., Crane, P. K., Gray, S. L., & Larson, E. B. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a18691 · Cited by 179
Kuehl, G. E., Lampe, J. W., Potter, J. D., & Bigler, J. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.002527 · Cited by 177
Nonsteroidal antiinflammatory drugs and uncoupling of mitochondrial oxidative phosphorylation
Mahmud, T., Rafi, S. S., Scott, D. L., Wrigglesworth, J. M., & Bjarnason, I. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391208 · Cited by 175
Sedation and Pain Management in Burn Patients
Griggs, C. L., Goverman, J. M., Bittner, E. A., & Lévi, B. (2017) · Clinics in Plastic Surgery · doi:10.1016/j.cps.2017.02.026 · Cited by 175
Chattopadhyay, I., Bandyopadhyay, U., Biswas, K., Maity, P., & Banerjee, R. K. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.12.016 · Cited by 173
Self-citationCurrent Perspectives in NSAID-Induced Gastropathy
Sinha, M., Gautam, L., Shukla, P., Kaur, P., Sharma, S., & Singh, T. P. (2013) · Mediators of Inflammation · doi:10.1155/2013/258209 · Cited by 172
Misguided drug advice for COVID-19
FitzGerald, G. A. (2020) · Science · doi:10.1126/science.abb8034 · Cited by 172
Emerging roles for cyclooxygenase‐2 in gastrointestinal mucosal defense
Wallace, J. L., & Devchand, P. R. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706201 · Cited by 168
Bandyopadhyay, U., Biswas, K., Chatterjee, R., Bandyopadhyay, D., Chattopadhyay, I., Ganguly, C. K., Chakraborty, T., Bhattacharya, K., & Banerjee, R. K. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)02143-4 · Cited by 167
Self-citationCyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management
Rawat, C., Kukal, S., Dahiya, U. R., & Kukreti, R. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1592-3 · Cited by 162
Coyle, C., Cafferty, F. H., Rowley, S., MacKenzie, M., Berkman, L., Gupta, S., Pramesh, C. S., Gilbert, D., Kynaston, H., Cameron, D., et al. (2016) · Contemporary Clinical Trials · doi:10.1016/j.cct.2016.10.004 · Cited by 161
Jana, N. R. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7511-x · Cited by 159
Watanabe, T., Fujiwara, Y., & Chan, F. K. L. (2019) · Journal of Gastroenterology · doi:10.1007/s00535-019-01657-8 · Cited by 155
ABCC2/Abcc2: a multispecific transporter with dominant excretory functions
Jemnitz, K., Herédi‐Szabó, K., Jánossy, J., Ioja, E., Vereczkey, L., & Krajcsi, P. (2010) · Drug Metabolism Reviews · doi:10.3109/03602530903491741 · Cited by 152
Current approaches to prevent NSAID‐induced gastropathy – COX selectivity and beyond
Becker, J. C., Domschke, W., & Pohle, T. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02198.x · Cited by 151
Nonsteroidal anti-inflammatory drugs for dysmenorrhoea
Marjoribanks, J., Proctor, M. L., Farquhar, C. M., & Derks, R. S. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001751.pub2 · Cited by 143
Maity, P., Bindu, S., Dey, S., Goyal, M., Alam, A., Pal, C., Mitra, K., & Bandyopadhyay, U. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805329200 · Cited by 141
Self-citationUse of NSAIDs in triathletes: prevalence, level of awareness and reasons for use
Gorski, T., Cadore, E. L., Pinto, S. S., Silva, E., Correa, C. S., Beltrami, F. G., & Kruel, L. F. M. (2009) · British Journal of Sports Medicine · doi:10.1136/bjsm.2009.062166 · Cited by 141
Hydrogen sulfide prodrugs—a review
Zheng, Y., Ji, X., Ji, K., & Wang, B. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.06.004 · Cited by 134
Endo, H., Higurashi, T., Hosono, K., Sakai, E., Sekino, Y., Iida, H., Sakamoto, Y., Koide, T., Takahashi, H., Yoneda, M., et al. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-011-0410-1 · Cited by 134
Qandil, A. M. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131217244 · Cited by 134
Laine, L., Curtis, S., Langman, M. J. S., Jensen, D. M., Cryer, B., Kaur, A., & Cannon, C. P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.067 · Cited by 133
Non-steroidal anti-inflammatory drug-induced enteropathy
Shin, S. J., Noh, C., Lim, S. G., Lee, K. M., & Lee, K. J. (2017) · Intestinal Research · doi:10.5217/ir.2017.15.4.446 · Cited by 132
Hydrogen Sulfide-Releasing Therapeutics: Translation to the Clinic
Wallace, J. L., Vaughan, D., Dicay, M. S., MacNaughton, W. K., & Nucci, G. D. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7068 · Cited by 130
Nonsteroidal anti-inflammatory drugs in colorectal cancer: from prevention to therapy
Ricchi, P., Zarrilli, R., di Palma, A., & Acquaviva, A. M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600829 · Cited by 129
Voiriot, G., Philippot, Q., Elabbadi, A., Elbim, C., Chalumeau, M., & Fartoukh, M. S. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8060786 · Cited by 128
Pal, C., Bindu, S., Dey, S., Alam, A., Goyal, M., Iqbal, M. S., Maity, P., Adhikari, S. S., & Bandyopadhyay, U. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.04.013 · Cited by 126
Self-citationPan, L., Qin, M., Liu, X., & Zhu, Y. Z. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00686 · Cited by 124
Lundberg, T. R., & Howatson, G. (2018) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.13275 · Cited by 124
Wallace, J. L., Nagy, P., Feener, T. D., Allain, T., Ditrói, T., Vaughan, D. J., Muscará, M. N., Nucci, G. D., & Buret, A. G. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14641 · Cited by 123
NSAIDs and cardiovascular risk
Marsico, F., Paolillo, S., & Filardi, P. P. (2016) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000443 · Cited by 121
Repurposing Drugs in Oncology (ReDO)—diclofenac as an anti-cancer agent
Pantziarka, P., Sukhatme, V. V., Bouche, G., Melhuis, L., & Sukhatme, V. P. (2016) · ecancermedicalscience · doi:10.3332/ecancer.2016.610 · Cited by 119
Tsoi, K. K. F., Ho, M.-W., Chan, F. C. H., & Sung, J. J. �. (2018) · International Journal of Cancer · doi:10.1002/ijc.32083 · Cited by 119
The fight against rheumatism: from willow bark to COX-1 sparing drugs.
Vane, J. R. (2000) · PubMed · Cited by 115
Repurposing of approved cardiovascular drugs
Ishida, J., Konishi, M., Ebner, N., & Springer, J. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-1031-5 · Cited by 115
Gelbenegger, G., Postula, M. A., Pecen, L., Halvorsen, S., Lesiak, M., Schoergenhofer, C., Jilma, B., Hengstenberg, C., & Siller-Matula, J. M. (2019) · BMC Medicine · doi:10.1186/s12916-019-1428-0 · Cited by 113
Gold, B. S., Pingle, M., Brickner, S. J., Shah, N., Roberts, J., Rundell, M. S., Bracken, W. C., Warrier, T., Somersan, S., Venugopal, A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214188109 · Cited by 111
Quantifying the impact of NSAID-associated adverse events.
Fine, M. J. (2013) · PubMed · Cited by 106
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Progress in Small Molecule Drug Development
Rao, P. P. N., Kabir, S. N., & Mohamed, T. (2010) · Pharmaceuticals · doi:10.3390/ph3051530 · Cited by 104
Fattori, V., Borghi, S. M., Guazelli, C. F., Giroldo, A. C., Crespigio, J., Bussmann, A. J. C., Coelho-Silva, L., Ludwig, N., Mazzuco, T., Casagrande, R., et al. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2016.12.039 · Cited by 104
Lohmander, S. L., McKeith, D., Svensson, O., Malmenäs, M., Bolin, L., Kalla, A., Genti, G., Szechinski, J., & Ramos-Remus, C. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.023572 · Cited by 102
Masubuchi, Y., Yamada, S. M., & Horie, T. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35379-0 · Cited by 102
Darling, R. L., Romero, J. J., Dial, E. J., Akunda, J. K., Langenbach, R. J., & Lichtenberger, L. M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.003 · Cited by 100
Cardiovascular complications of non-steroidal anti-inflammatory drugs.
Fosslien, E. (2005) · PubMed · Cited by 100
Mazumder, S., De, R., Debsharma, S., Bindu, S., Maity, P., Sarkar, S., Saha, S. J., Siddiqui, A. A., Banerjee, C., Nag, S., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004415 · Cited by 99
Self-citationJoo, Y., Kim, H., Woo, R., Park, C. H., Shin, K.-Y., Lee, J., Chang, K., Kim, S., & Suh, Y. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.015206 · Cited by 97
Advances in antitumor effects of NSAIDs
Zhang, Z., Chen, F., & Shang, L. (2018) · Cancer Management and Research · doi:10.2147/cmar.s175212 · Cited by 97
Introduction: Mechanism of Action of NSAIDs
Vane, J. R. (1996) · Rheumatology · doi:10.1093/rheumatology/35.suppl_1.1 · Cited by 96
Zhao-Fleming, H. H., Hand, A., Zhang, K., Polák, R., Northcut, A., Jacob, D., Dissanaike, S. D., & Rumbaugh, K. P. (2018) · Burns & Trauma · doi:10.1186/s41038-018-0128-x · Cited by 95
Significant Acute Kidney Injury Due to Non-steroidal Anti-inflammatory Drugs: Inpatient Setting
Dixit, M. P., Doan, T., Kirschner, R., & Dixit, N. M. (2010) · Pharmaceuticals · doi:10.3390/ph3041279 · Cited by 94
Ejaz, P., Bhojani, K. S., & Joshi, V. (2004) · PubMed · Cited by 93
NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: What lies beyond the horizon
Fiorucci, S., Santucci, L., & Distrutti, E. (2007) · Digestive and Liver Disease · doi:10.1016/j.dld.2007.09.001 · Cited by 92
Maity, P., Bindu, S., Dey, S., Goyal, M., Alam, A., Pal, C., Reiter, R. J., & Bandyopadhyay, U. (2009) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2009.00663.x · Cited by 91
Self-citationRisk of Stroke Associated With Nonsteroidal Anti-Inflammatory Drugs
Bak, S., Andersen, M. T., Tsiropoulos, I., Rodríguez, L. A. G., Hallas, J., Christensen, K., & Gaist, D. (2003) · Stroke · doi:10.1161/01.str.0000053029.45352.a0 · Cited by 87
Non-steroid anti-inflammatory drugs, prostaglandins, and cancer
Allaj, V., Guo, C., & Nie, D. (2013) · Cell & Bioscience · doi:10.1186/2045-3701-3-8 · Cited by 86
FDA labeling of NSAIDs: Review of nonsteroidal anti-inflammatory drugs in cardiovascular disease
Pirlamarla, P. R., & Bond, R. M. (2016) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2016.04.011 · Cited by 84
Bolder, U., Trang, N. V., Hagey, L. R., Schteingart, C. D., Ton‐Nu, H., Cerré, C., Elferink, R. P. J. O., & Hofmann, A. F. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70356-2 · Cited by 82
Nimesulide-induced hepatotoxicity: A systematic review and meta-analysis
Kwon, J., Kim, S., Yoo, H., & Lee, E. (2019) · PLoS ONE · doi:10.1371/journal.pone.0209264 · Cited by 82
Fu, Y., Wu, H., Cui, H., Li, Y.-B., & Li, C. (2018) · Phytotherapy Research · doi:10.1002/ptr.6148 · Cited by 76
Nitric oxide in the gastrointestinal tract: opportunities for drug development
Wallace, J. L. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14527 · Cited by 75
Lago, E. M., Silva, M. P., de Queiroz, T. G. A., Mazloum, S. F., Rodrigues, V. C., Carnaúba, P. U., Pinto, P. L. S., Rocha, J. A., Ferreira, L. L. G., Andricopulo, A. D., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.04.029 · Cited by 75
Mortensen, B., Murphy, C. L., O’Grady, J., Lucey, M., Elsafi, G., Barry, L., Westphal, V., Wellejus, A., Lukjančenko, O., Eklund, A. C., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.05.008 · Cited by 74
Nadatani, Y., Watanabe, T., Tanigawa, T., Machida, H., Okazaki, H., Yamagami, H., Watanabe, K., Tominaga, K., Fujiwara, Y., & Arakawa, T. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.03.039 · Cited by 73
Schink, T., Kollhorst, B., Varas‐Lorenzo, C., Arfè, A., Herings, R. M. C., Lucchi, S. R., Romio, S., Schade, R., Schuemie, M. J., Straatman, H., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203362 · Cited by 72
Magee, D. J., Jhanji, S., Poulogiannis, G., Farquhar-Smith, P. W., & Brown, M. R. D. (2019) · British Journal of Anaesthesia · doi:10.1016/j.bja.2019.02.028 · Cited by 70
Joharatnam‐Hogan, N., Cafferty, F. H., Hubner, R. A., Swinson, D., Sothi, S., Gupta, K., Falk, S. J., Patel, K., Warner, N., Kunene, V., et al. (2019) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(19)30289-4 · Cited by 70
Coronary Risks Associated with Diclofenac and Other NSAIDs: An Update
Moore, N. D. (2020) · Drug Safety · doi:10.1007/s40264-019-00900-8 · Cited by 70
Bindu, S., Mazumder, S., Dey, S., Pal, C., Goyal, M., Alam, A., Iqbal, M. S., Sarkar, S., Siddiqui, A. A., Banerjee, C., et al. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.07.027 · Cited by 69
Self-citationTacconelli, S., Bruno, A., Grande, R., Ballerini, P., & Patrignani, P. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1338272 · Cited by 69
Systematic review: ibuprofen‐induced liver injury
Zoubek, M. E., Lucena, M. I., Andrade, R. J., & Stephens, C. M. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15645 · Cited by 69
Risk of stroke associated with nonsteroidal anti-inflammatory drugs
Bavry, A. A., & Park, K. E. (2014) · Vascular Health and Risk Management · doi:10.2147/vhrm.s54159 · Cited by 67
Chattopadhyay, I., Nandi, B., Chatterjee, R., Biswas, K., Bandyopadhyay, U., & Banerjee, R. K. (2004) · Inflammopharmacology · doi:10.1163/1568560041352257 · Cited by 67
Self-citationThe Invisible Threat of Non-steroidal Anti-inflammatory Drugs for Kidneys
Clave, S., Rousset‐Rouvière, C., Daniel, L., & Tsimaratos, M. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00520 · Cited by 67
Kirkby, N. S., Zaiss, A. K., Urquhart, P., Jiao, J., Austin, P. J., Al-Yamani, M., Lundberg, M. H., Mackenzie, L. S., Warner, T. D., Nicolaou, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069524 · Cited by 66
Repurposing of Aspirin and Ibuprofen as Candidate Anti-Cryptococcus Drugs
Ogundeji, A. O., Pohl, C. H., & Sebolai, O. M. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02810-15 · Cited by 66
Hendrix, A. S., Spoonmore, T. J., Wilde, A. D., Putnam, N. E., Hammer, N. D., Snyder, D. J., Guelcher, S. A., Skaar, E. P., & Cassat, J. E. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00834-16 · Cited by 66
Diclofenac induces proteasome and mitochondrial dysfunction in murine cardiomyocytes and hearts
Ghosh, R., Goswami, S. K., Feitoza, L. F. B. B., Hammock, B. D., & Gomes, A. V. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.08.233 · Cited by 65
Ahmad, M. H., Fatima, M., Hossain, M., & Mondal, A. C. (2018) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2018.04.002 · Cited by 64
Aspirin Exacerbated Respiratory Disease: Epidemiology, Pathophysiology, and Management
Li, K. L., Lee, A. Y., & Abuzeid, W. M. (2019) · Medical Sciences · doi:10.3390/medsci7030045 · Cited by 64
Huang, C., Chen, Y., Liu, H., Yang, J., Song, X., Zhao, J., He, N., Zhou, C. J., Wang, Y., Huang, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.23250 · Cited by 63
Shebl, F. M., Hsing, A. W., Park, Y., Hollenbeck, A. R., Chu, L. W., Meyer, T. E., & Koshiol, J. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114633 · Cited by 59
Wen, Y., Hsiao, F., Chan, K. A., Lin, Z., Shen, L., & Fang, C. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw603 · Cited by 58
Indomethacin-induced renal damage: role of oxygen free radicals
Basivireddy, J., Jacob, M., Pulimood, A. B., & Balasubramanian, K. A. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.09.023 · Cited by 56
Recent Advances in Hepatotoxicity of Non Steroidal Anti-inflammatory Drugs
Meunier, L., & Larrey, D. G. (2018) · Annals of Hepatology · doi:10.5604/01.3001.0010.8633 · Cited by 56
Nadatani, Y., Watanabe, T., Suda, W., Nakata, A., Matsumoto, Y., Kosaka, S., Higashimori, A., Otani, K., Hosomi, S., Tanaka, F., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-53559-7 · Cited by 56
Cunningham, C. M., & Skelly, D. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9312-5 · Cited by 55
Lobb, I., Sonke, E., Aboalsamh, G. A., & Şener, A. (2014) · Nitric Oxide · doi:10.1016/j.niox.2014.10.004 · Cited by 55
Suzuki, T., Masui, A., Nakamura, J., Shiozawa, H., Aoki, J., Nakae, H., Tsuda, S., Imai, J., Ozawa, H., Matsushima, M., et al. (2017) · Digestion · doi:10.1159/000452361 · Cited by 54
A perspective review on role of novel NSAID prodrugs in the management of acute inflammation
Peesa, J. P., Yalavarthi, P. R., Rasheed, A., & Mandava, V. B. R. (2016) · Journal of Acute Disease · doi:10.1016/j.joad.2016.08.002 · Cited by 53
Salvo, F., Antoniazzi, S., Duong, M., Molimard, M., Bazin, F., Fourrier‐Réglat, A., Pariente, A., & Moore, N. D. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.907792 · Cited by 52
Role of bile in pathogenesis of indomethacin-induced enteropathy
Jacob, M., Foster, R., Sigthorsson, G., Simpson, R. J., & Bjarnason, I. (2006) · Archives of Toxicology · doi:10.1007/s00204-006-0149-2 · Cited by 48
Pharmacogenetics of nonsteroidal anti-inflammatory drugs
Wyatt, J. E., Pettit, W. L., & Harirforoosh, S. (2012) · The Pharmacogenomics Journal · doi:10.1038/tpj.2012.40 · Cited by 47
Zatelli, M. C., Luchin, A., Tagliati, F., Leoni, S., Piccin, D., Bondanelli, M., Rossi, R., & Uberti, E. C. D. (2007) · Endocrine Related Cancer · doi:10.1677/erc-07-0114 · Cited by 47
Mazumder, S., De, R., Sarkar, S., Siddiqui, A. A., Saha, S. J., Banerjee, C., Iqbal, M. S., Nag, S., Debsharma, S., & Bandyopadhyay, U. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.09.027 · Cited by 47
Self-citationThe Immunobiology of Prostanoid Receptor Signaling in Connecting Innate and Adaptive Immunity
Harizi, H. (2013) · BioMed Research International · doi:10.1155/2013/683405 · Cited by 46
Braun, F., Al‐Yacoub, N., Plötz, M., Möbs, M., Sterry, W., & Eberle, J. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.316 · Cited by 44
Salicylic acid-induced hepatotoxicity triggered by oxidative stress
Doi, H., & Horie, T. (2009) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2009.11.024 · Cited by 42
Non-steroidal Anti-inflammatory Drugs (NSAIDs) Systemic Use: The Risk of Renal Failure
BENSMAN, A. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00517 · Cited by 39
Role of Group 2 Innate Lymphocytes in Aspirin-exacerbated Respiratory Disease Pathogenesis
White, A. A., & Doherty, T. A. (2018) · American Journal of Rhinology and Allergy · doi:10.2500/ajra.2018.32.4498 · Cited by 38
The multisystem adverse effects of NSAID therapy
James, D. S. (1999) · The Journal of the American Osteopathic Association · doi:10.7556/jaoa.1999.99.11.s1 · Cited by 36
Hegab, I. I., Abd‐Ellatif, R. N., & Sadek, M. T. (2018) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2017-0730 · Cited by 35
Nonsteroidal Antiinflammatory Drugs, Cyclooxygenase-2, and the Kidneys
Rahman, S., & Malcoun, A. (2014) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2014.09.001 · Cited by 34
Chatterjee, S., Dureja, G. P., Kadhe, G., Mane, A., Phansalkar, A. A., Sawant, S., & Kapatkar, V. K. (2015) · Gastroenterology Research · doi:10.14740/gr658w · Cited by 32
The prevalence of endoscopic gastric mucosal damage in patients with rheumatoid arthritis
Tsujimoto, S., Mokuda, S., Matoba, K., Yamada, A., Jouyama, K., Murata, Y., Ozaki, Y., Ito, T., Nomura, S., & Okuda, Y. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200023 · Cited by 31
NSAID Use and Incident Cognitive Impairment in a Population-based Cohort
Wichmann, M. A., Cruickshanks, K. J., Carlsson, C. M., Chappell, R. J., Fischer, M., Klein, R., Klein, R., & Schubert, C. R. (2015) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000098 · Cited by 29
Nonaspirin Nonsteroidal Anti-inflammatory Drugs and Hemorrhagic Stroke Risk
Choi, N., Park, B., Jeong, S., Yu, K., & Yoon, B. (2008) · Stroke · doi:10.1161/strokeaha.107.497040 · Cited by 28
Farrugia, G., & Balzan, R. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/504230 · Cited by 27
Ko, I., Jin, J., Hwang, L., Kim, S., Kim, C., Han, J., Kwak, M. S., Yoon, J. Y., & Jeon, J. W. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.172952 · Cited by 27
Whitfield-Cargile, C., Cohen, N. D., He, K., Ivanov, I. V., Goldsby, J. S., Chamoun‐Emanuelli, A. M., Weeks, B. R., Davidson, L. A., & Chapkin, R. S. (2017) · Scientific Reports · doi:10.1038/s41598-017-13999-5 · Cited by 24
Chittepu, V. C. S. R., Kalhotra, P., Osorio-Gallardo, T., Gallardo‐Velázquez, T., & Osorio-Revilla, G. I. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11050238 · Cited by 23
Shimada, S., Tanigawa, T., Watanabe, T., Nakata, A., Sugimura, N., Itani, S., Higashimori, A., Nadatani, Y., Otani, K., Taira, K., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211436 · Cited by 22
Lefebvre, C. E., Hindié, J., Zappitelli, M., Platt, R., & Filion, K. (2019) · Clinical Kidney Journal · doi:10.1093/ckj/sfz054 · Cited by 22
Steckling, F. M., Lima, F. D., Farinha, J. B., da Rosa, P. C., Royes, L. F. F., Cuevas, M. J., Bresciani, G., Soares, F. A. A., González‐Gallego, J., & Barcelos, R. P. (2019) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.13579 · Cited by 22
Li, J., & Mansmann, U. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072477 · Cited by 18
Ricciotti, E., Castro, C., Tang, S. Y., Briggs, W. T. E., West, J. A., Malik, D. M., Rhoades, S. D., Meng, H., Li, X., Lahens, N. F., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.033540 · Cited by 15
Cerebral microbleeds in patients with ischemic cerebrovascular disease taking aspirin or clopidogrel
Ge, L., Ouyang, X., Chao, B., Yu, H., Wu, Q., Wu, H., & Liang, J. (2019) · Medicine · doi:10.1097/md.0000000000014685 · Cited by 11
PROSPECTIVE MONITORING OF DRUG USE: DRUG-INDUCED LIVER INJURY IN A PRIMARY HEALTHCARE CENTER
Prado, N. M. D. B. L., Messias, G. C., Santos, G., Nunes, V., Schinonni, M. I., & Paraná, R. (2019) · Arquivos de Gastroenterologia · doi:10.1590/s0004-2803.201900000-73 · Cited by 11
Aspirin and intracerebral hemorrhage
Behrouz, R., & Miller, C. (2015) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000089 · Cited by 10
Ahmetaj‐Shala, B., Kirkby, N. S., Knowles, R., Al-Yamani, M., Mazi, S. I., Wang, Z., Tucker, A. T., Mackenzie, L. S., Armstrong, P. C. J., Nüsing, R. M., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.017260 · Cited by 4
Cited by
GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
Zhao, X., Wang, M., Wen, Z., Lu, Z., Cui, L., Fu, C., Xue, H., Liu, Y., & Zhang, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.721135 · Cited by 463
“Therefore, the use of NSAIDs is usually associated with damage to the gastrointestinal tract and other systems during treatment, and thus need to be used with caution (95).”
BackgroundMitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management
Jin, P., Jiang, J., Zhou, L., Huang, Z., Nice, E. C., Huang, C., & Fu, L. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01313-4 · Cited by 273
Knee osteoarthritis: Current status and research progress in treatment (Review)
Geng, R., Li, J., Yu, C., Zhang, C., Chen, F., Chen, J., Ni, H., Wang, J., Kang, K., Wei, Z., et al. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.12180 · Cited by 266
Traditional herbal medicine: Therapeutic potential in rheumatoid arthritis
Wang, Y., Chen, S., Du, K., Liang, C., Wang, S., Owusu Boadi, E., Li, J., Pang, X., He, J., & Chang, Y.-X. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114368 · Cited by 264
Sohail, R., Mathew, M., Patel, K. K., Reddy, S. A., Haider, Z., Naria, M., Habib, A., Abdin, Z. U., Razzaq Chaudhry, W., & Akbar, A. (2023) · Cureus · doi:10.7759/cureus.37080 · Cited by 239
Metadata
- Authors
- Bindu, S., Mazumder, S., & Bandyopadhyay, U.
- Venue
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Published
- 2020-10
- Volume
- 180
- Pages
- 114147
- ISSN
- 0006-2952 (ISSN-L)
- OpenAlex
- W3041720930
- Cited by
- 1,920
- References
- 195
- FWCI
- 88.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.